EU secures 405 million vaccinations through Curevac acquisition
EU Secures 705 Million Doses of COVID-19 Vaccines from Biontech and Curevac
The European Union (EU) has made significant strides in securing coronavirus vaccines, with agreements in place for 705 million doses from Biontech and Curevac.
On Monday afternoon, EU Commission President Ursula von der Leyen announced that the EU has secured 300 million doses from Biontech, following the company's announcement last week of an effectiveness of 90 percent for their vaccine. This agreement comes after the EU had already secured 300 million doses from Biontech earlier.
In a separate announcement, von der Leyen revealed that the EU has agreed to receive 405 million doses of Curevac's Corona vaccine. However, it's important to note that the deliveries of CureVac vaccines never materialized, despite the orders existing. The effectiveness and tolerability of Curevac's vaccine are still under testing.
Negotiations with Moderna are ongoing for up to 160 million doses of their Corona vaccine, which has been announced to have an almost 95 percent effectiveness. No new information about the start, progress, or results of the testing phases of the Curevac, Moderna, or Biontech vaccines is provided in the current news.
The European flag is featured in the image accompanying this news article, as provided by dts Nachrichtenagentur.
As the world continues to grapple with the pandemic, the EU's efforts to secure vaccines are a significant step towards combating the spread of COVID-19. The EU's commitment to ensuring the availability of vaccines for its citizens is commendable and offers a glimmer of hope in these challenging times.
Stay tuned for more updates as the situation develops.
Read also:
- Overweight women undergoing IVF have a 47% higher chance of conceiving naturally post-weight loss
- Bonsai Trees from Evergreen Species: Exploring Growth Characteristics & Distinct Qualities
- What temperatures may make walking your canine companion uncomfortable?
- Title: Information About Beovu: Potency, Form, Usage, and Additional Details
